386 related articles for article (PubMed ID: 30626823)
1. The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.
Ogawa S; Suzuki M; Ochi H; Saji M; Mahara K; Takamisawa I; Nishigawa K; Furuichi Y; Takanashi S; Isobe M
Intern Med; 2019 May; 58(10):1459-1462. PubMed ID: 30626823
[TBL] [Abstract][Full Text] [Related]
2. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry.
Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK
J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180
[TBL] [Abstract][Full Text] [Related]
3. First successful bridge to recovery with the Impella Recover 100 left ventricular assist device for fulminant acute myocarditis.
Colombo T; Garatti A; Bruschi G; Lanfranconi M; Russo C; Milazzo F; Catena E; Frigerio M; Vitali E
Ital Heart J; 2003 Sep; 4(9):642-5. PubMed ID: 14635384
[TBL] [Abstract][Full Text] [Related]
4. Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump.
Andrade JG; Al-Saloos H; Jeewa A; Sandor GG; Cheung A
J Heart Lung Transplant; 2010 Jan; 29(1):96-7. PubMed ID: 19782584
[TBL] [Abstract][Full Text] [Related]
5. Less Invasive Left Ventricular Unloading With Impella May Improve the Clinical Outcomes of Fulminant Myocarditis.
Kawamura T; Toda K; Yoshioka D; Kawamura M; Saito T; Kawamura A; Nakamoto K; Sakata Y; Miyagawa S
ASAIO J; 2023 Jun; 69(6):561-568. PubMed ID: 36848874
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
Seyfarth M; Sibbing D; Bauer I; Fröhlich G; Bott-Flügel L; Byrne R; Dirschinger J; Kastrati A; Schömig A
J Am Coll Cardiol; 2008 Nov; 52(19):1584-8. PubMed ID: 19007597
[TBL] [Abstract][Full Text] [Related]
7. Timing of conversion from percutaneous cardiopulmonary support system to left ventricular assist system for severe fulminant myocarditis.
Tayama E; Aoyagi S
Ann Thorac Cardiovasc Surg; 2010 Aug; 16(4):301-2; author reply 302. PubMed ID: 21057453
[No Abstract] [Full Text] [Related]
8. Trans-subclavian approach for Impella CP implantation using the chimney graft in a pediatric patient with fulminant myocarditis during extracorporeal support.
Hirose M; Ishida H; Kawamura T; Narita J; Ishii R; Watanabe T; Taira M; Ueno T; Ozono K; Miyagawa S
J Artif Organs; 2023 Sep; 26(3):242-245. PubMed ID: 36224293
[TBL] [Abstract][Full Text] [Related]
9. Successful management of fulminant myocarditis with left ventricular assist device: report of a severe case.
Unosawa S; Hata M; Sezai A; Niino T; Yoshitake I; Shimura K; Takamori T; Minami K
Ann Thorac Cardiovasc Surg; 2010 Aug; 16(1):48-51. PubMed ID: 20190711
[TBL] [Abstract][Full Text] [Related]
10. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
[TBL] [Abstract][Full Text] [Related]
11. Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock.
Bohné M; Chung DU; Tigges E; van der Schalk H; Waddell D; Schenker N; Willems S; Klingel K; Kivelitz D; Bahlmann E
BMC Cardiovasc Disord; 2020 Dec; 20(1):519. PubMed ID: 33302874
[TBL] [Abstract][Full Text] [Related]
12. Outcome of the impella device for acute mechanical circulatory support.
Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G
Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788
[TBL] [Abstract][Full Text] [Related]
13. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
Engström AE; Granfeldt H; Seybold-Epting W; Dahm M; Cocchieri R; Driessen AH; Sjauw KD; Vis MM; Baan J; Koch KT; De Jong M; Lagrand WK; Van Der Sloot JA; Tijssen JG; De Winter RJ; De Mol BA; Piek JJ; Henriques JP
Minerva Cardioangiol; 2013 Oct; 61(5):539-46. PubMed ID: 24096248
[TBL] [Abstract][Full Text] [Related]
14. Successful combined use of Impella Recover 2.5 device and intra-aortic balloon pump support in cardiogenic shock from acute myocardial infarction.
Wiktor DM; Sawlani N; Kanthi Y; Sipahi I; Fang JC; Blitz A
ASAIO J; 2010; 56(6):519-21. PubMed ID: 20938341
[TBL] [Abstract][Full Text] [Related]
15. Successful cases of percutaneous left ventricular assist device "Impella" to fulminant myocarditis.
Hori T; Iida M; Uchiyama M; Shimokawa T
J Cardiothorac Surg; 2022 Apr; 17(1):72. PubMed ID: 35414115
[TBL] [Abstract][Full Text] [Related]
16. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
[TBL] [Abstract][Full Text] [Related]
17. In vitro comparison of support capabilities of intra-aortic balloon pump and Impella 2.5 left percutaneous.
Schampaert S; van't Veer M; van de Vosse FN; Pijls NH; de Mol BA; Rutten MC
Artif Organs; 2011 Sep; 35(9):893-901. PubMed ID: 21819436
[TBL] [Abstract][Full Text] [Related]
18. Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy.
Pahuja M; Hernandez-Montfort J; Whitehead EH; Kawabori M; Kapur NK
Expert Rev Med Devices; 2022 Jan; 19(1):1-10. PubMed ID: 34894975
[TBL] [Abstract][Full Text] [Related]
19. Fulminant myocarditis in adults and children: bi-ventricular assist device for recovery.
Grinda JM; Chevalier P; D'Attellis N; Bricourt MO; Berrebi A; Guibourt P; Fabiani JN; Deloche A
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1169-73. PubMed ID: 15541979
[TBL] [Abstract][Full Text] [Related]
20. [The Impella system for mechanical support and myocardial recovery].
Engström AE; de Mol BA; Lagrand WK; Henriques JP
Ned Tijdschr Geneeskd; 2010; 154(45):A2699. PubMed ID: 21118589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
